ICD-10-CM Code H35.32

Exudative age-related macular degeneration

Version 2021 Replaced Code Non-Billable Code

Not Valid for Submission

H35.32 is a "header" nonspecific and non-billable code code, consider using a code with a higher level of specificity for a diagnosis of exudative age-related macular degeneration. The code is NOT valid for the year 2021 for the submission of HIPAA-covered transactions.

ICD-10:H35.32
Short Description:Exudative age-related macular degeneration
Long Description:Exudative age-related macular degeneration

Consider the following ICD-10 codes with a higher level of specificity:

  • H35.321 - ... right eye
  • H35.3210 - ... right eye, stage unspecified
  • H35.3211 - ... right eye, with active choroidal neovascularization
  • H35.3212 - ... right eye, with inactive choroidal neovascularization
  • H35.3213 - ... right eye, with inactive scar
  • H35.322 - ... left eye
  • H35.3220 - ... left eye, stage unspecified
  • H35.3221 - ... left eye, with active choroidal neovascularization
  • H35.3222 - ... left eye, with inactive choroidal neovascularization
  • H35.3223 - ... left eye, with inactive scar
  • H35.323 - ... bilateral
  • H35.3230 - ... bilateral, stage unspecified
  • H35.3231 - ... bilateral, with active choroidal neovascularization
  • H35.3232 - ... bilateral, with inactive choroidal neovascularization
  • H35.3233 - ... bilateral, with inactive scar
  • H35.329 - ... unspecified eye
  • H35.3290 - ... unspecified eye, stage unspecified
  • H35.3291 - ... unspecified eye, with active choroidal neovascularization
  • H35.3292 - ... unspecified eye, with inactive choroidal neovascularization
  • H35.3293 - ... unspecified eye, with inactive scar

Replaced Code

This code was replaced in the 2021 ICD-10 code set with the code(s) listed below. The National Center for Health Statistics (NCHS) has published an update to the ICD-10-CM diagnosis codes which became effective October 1, 2020. This code was replaced for the FY 2021 (October 1, 2020 - September 30, 2021).

  • H35.3210 - Exudative age-rel mclr degn, right eye, stage unspecified
  • H35.3210 - Exudative age-rel mclr degn, right eye, stage unspecified
  • H35.3211 - Exdtve age-rel mclr degn, right eye, with actv chrdl neovas
  • H35.3211 - Exdtve age-rel mclr degn, right eye, with actv chrdl neovas
  • H35.3212 - Exdtve age-rel mclr degn, right eye, with inact chrdl neovas
  • H35.3212 - Exdtve age-rel mclr degn, right eye, with inact chrdl neovas
  • H35.3213 - Exudative age-rel mclr degn, right eye, with inactive scar
  • H35.3213 - Exudative age-rel mclr degn, right eye, with inactive scar
  • H35.3220 - Exudative age-related mclr degn, left eye, stage unspecified
  • H35.3220 - Exudative age-related mclr degn, left eye, stage unspecified
  • H35.3221 - Exdtve age-rel mclr degn, left eye, with actv chrdl neovas
  • H35.3221 - Exdtve age-rel mclr degn, left eye, with actv chrdl neovas
  • H35.3222 - Exdtve age-rel mclr degn, left eye, with inact chrdl neovas
  • H35.3222 - Exdtve age-rel mclr degn, left eye, with inact chrdl neovas
  • H35.3223 - Exudative age-rel mclr degn, left eye, with inactive scar
  • H35.3223 - Exudative age-rel mclr degn, left eye, with inactive scar
  • H35.3230 - Exudative age-rel mclr degn, bilateral, stage unspecified
  • H35.3230 - Exudative age-rel mclr degn, bilateral, stage unspecified
  • H35.3231 - Exudative age-rel mclr degn, bi, with actv chrdl neovas
  • H35.3231 - Exudative age-rel mclr degn, bi, with actv chrdl neovas
  • H35.3232 - Exudative age-rel mclr degn, bi, with inact chrdl neovas
  • H35.3232 - Exudative age-rel mclr degn, bi, with inact chrdl neovas
  • H35.3233 - Exudative age-rel mclr degn, bilateral, with inactive scar
  • H35.3233 - Exudative age-rel mclr degn, bilateral, with inactive scar
  • H35.3290 - Exudative age-related mclr degn, unsp, stage unspecified
  • H35.3290 - Exudative age-related mclr degn, unsp, stage unspecified
  • H35.3291 - Exudative age-rel mclr degn, unsp, with actv chrdl neovas
  • H35.3291 - Exudative age-rel mclr degn, unsp, with actv chrdl neovas
  • H35.3292 - Exudative age-rel mclr degn, unsp, with inact chrdl neovas
  • H35.3292 - Exudative age-rel mclr degn, unsp, with inact chrdl neovas
  • H35.3293 - Exudative age-related mclr degn, unsp, with inactive scar
  • H35.3293 - Exudative age-related mclr degn, unsp, with inactive scar

Tabular List of Diseases and Injuries

The Tabular List of Diseases and Injuries is a list of ICD-10 codes, organized "head to toe" into chapters and sections with guidance for inclusions, exclusions, descriptions and more. The following references are applicable to the code H35.32:

Inclusion Terms

Inclusion Terms
These terms are the conditions for which that code is to be used. The terms may be synonyms of the code title, or, in the case of "other specified" codes, the terms are a list of the various conditions assigned to that code. The inclusion terms are not necessarily exhaustive. Additional terms found only in the Alphabetic Index may also be assigned to a code.
  • Wet age-related macular degeneration

7th Character Note

7th Character Note
Certain ICD-10-CM categories have applicable 7th characters. The applicable 7th character is required for all codes within the category, or as the notes in the Tabular List instruct. The 7th character must always be the 7th character in the data field. If a code that requires a 7th character is not 6 characters, a placeholder X must be used to fill in the empty characters.
  • One of the following 7th characters is to be assigned to codes in subcategory H35.32 to designate the stage of the disease:

7th Character

7th Character
Indicates that a seventh character is to be assigned to codes in a subcategory.
  • 0 - stage unspecified
  • 1 - with active choroidal neovascularization
  • 2 - with inactive choroidal neovascularization
  • with involuted or regressed neovascularization
  • 3 - with inactive scar

Index to Diseases and Injuries

The Index to Diseases and Injuries is an alphabetical listing of medical terms, with each term mapped to one or more ICD-10 code(s). The following references for the code H35.32 are found in the index:


Code Classification

  • Diseases of the eye and adnexa (H00–H59)
    • Disorders of choroid and retina (H30-H36)
      • Other retinal disorders (H35)

Code History

  • FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016
    (First year ICD-10-CM implemented into the HIPAA code set)
  • FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
  • FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
  • FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
  • FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
  • FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021

Information for Patients


Macular Degeneration

Also called: AMD, Age-related macular degeneration

Macular degeneration, or age-related macular degeneration (AMD), is a leading cause of vision loss in Americans 60 and older. It is a disease that destroys your sharp, central vision. You need central vision to see objects clearly and to do tasks such as reading and driving.

AMD affects the macula, the part of the eye that allows you to see fine detail. It does not hurt, but it causes cells in the macula to die. There are two types: wet and dry. Wet AMD happens when abnormal blood vessels grow under the macula. These new blood vessels often leak blood and fluid. Wet AMD damages the macula quickly. Blurred vision is a common early symptom. Dry AMD happens when the light-sensitive cells in the macula slowly break down. Your gradually lose your central vision. A common early symptom is that straight lines appear crooked.

Regular comprehensive eye exams can detect macular degeneration before the disease causes vision loss. Treatment can slow vision loss. It does not restore vision.

NIH: National Eye Institute

  • Fluorescein angiography (Medical Encyclopedia)
  • Home vision tests (Medical Encyclopedia)
  • Intravitreal injection (Medical Encyclopedia)
  • Macular degeneration - age-related (Medical Encyclopedia)

[Learn More]

Age-related macular degeneration Age-related macular degeneration is an eye disease that is a leading cause of vision loss in older people in developed countries. Subtle abnormalities indicating changes in vision may occur in a person's forties or fifties. Distorted vision and vision loss usually become noticeable in a person's sixties or seventies and tend to worsen over time.Age-related macular degeneration mainly affects central vision, which is needed for detailed tasks such as reading, driving, and recognizing faces. The vision loss in this condition results from a gradual deterioration of light-sensing cells in the tissue at the back of the eye that detects light and color (the retina). Specifically, age-related macular degeneration affects a small area near the center of the retina, called the macula, which is responsible for central vision. Side (peripheral) vision and night vision are generally not affected, but slow adjustment of vision to darkness (dark adaptation) and reduced dim light (scotopic) vision often occur in the early stages of the disease.Researchers have described two major types of age-related macular degeneration, known as the dry form and the wet form. The dry form is much more common, accounting for 85 to 90 percent of all cases of age-related macular degeneration. It is characterized by a buildup of yellowish deposits called drusen beneath the retina and vision loss that worsens slowly over time. The most advanced stage of dry age-related macular degeneration is known as geographic atrophy, in which areas of the macula waste away (atrophy), resulting in severe vision loss. Dry age-related macular degeneration typically affects vision in both eyes, although vision loss often occurs in one eye before the other.In 10 to 15 percent of affected individuals, the dry form progresses to the wet form of age-related macular degeneration. The wet form is characterized by the growth of abnormal, fragile blood vessels underneath the macula. These vessels leak blood and fluid, which damages the macula and makes central vision appear blurry and distorted. The wet form of age-related macular degeneration is associated with severe vision loss that can worsen rapidly.
[Learn More]